GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cuorips Inc (TSE:4894) » Definitions » FCF Margin %

Cuorips (TSE:4894) FCF Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Cuorips FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cuorips's Free Cash Flow for the three months ended in Sep. 2024 was 円0.00 Mil. Cuorips's Revenue for the three months ended in Sep. 2024 was 円0.00 Mil. Therefore, Cuorips's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, Cuorips's current FCF Yield % is -0.69%.

The historical rank and industry rank for Cuorips's FCF Margin % or its related term are showing as below:

TSE:4894' s FCF Margin % Range Over the Past 10 Years
Min: -432260.91   Med: -1950.52   Max: -1076.8
Current: -2108.08


During the past 4 years, the highest FCF Margin % of Cuorips was -1076.80%. The lowest was -432260.91%. And the median was -1950.52%.

TSE:4894's FCF Margin % is ranked worse than
84.21% of 1007 companies
in the Biotechnology industry
Industry Median: -127.22 vs TSE:4894: -2108.08


Cuorips FCF Margin % Historical Data

The historical data trend for Cuorips's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cuorips FCF Margin % Chart

Cuorips Annual Data
Trend Mar21 Mar22 Mar23 Mar24
FCF Margin %
-432,260.91 -1,792.95 -1,076.80 -2,108.08

Cuorips Quarterly Data
Mar21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
FCF Margin % Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Cuorips's FCF Margin %

For the Biotechnology subindustry, Cuorips's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cuorips's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cuorips's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cuorips's FCF Margin % falls into.


;
;

Cuorips FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cuorips's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=-487.008/23.102
=-2,108.08 %

Cuorips's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cuorips FCF Margin % Related Terms

Thank you for viewing the detailed overview of Cuorips's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cuorips Business Description

Traded in Other Exchanges
N/A
Address
3-11-5 Nihonbashi-Honcho, 507, Nihonbashi Life Science Building 2, Chuo-ku, Tokyo, JPN, 103-0023
Cuorips Inc is engaged in the Research, development, manufacturing, and sales of Cellular and Tissue-based Products and Cell processing products. The company is also engaged in Contract development and manufacturing services and consulting services of Cellular and Tissue-based Products and Cell processing product.

Cuorips Headlines

No Headlines